Cargando…
Methotrexate as a safe immunosuppressive agent during the COVID-19 pandemic
BACKGROUND: During the ongoing COVID-19 pandemic, immunocompromised patients are at a higher risk of severe infection, since the immune system has an important role in defeating this disease. This study compares the severity of COVID-19 in patients taking methotrexate with the severity of their fami...
Autores principales: | Ganjei, Zakiye, Faraji Dana, Hoorvash, Ebrahimi-Dehkordi, Sepehr, Alidoust, Fereshte, Bahmani, Kiumars |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8556580/ https://www.ncbi.nlm.nih.gov/pubmed/34731780 http://dx.doi.org/10.1016/j.intimp.2021.108324 |
Ejemplares similares
-
A case report of toxic leukoencephalopathy induced by metronidazole in a woman with surgical site infection
por: Faraji Dana, Hoorvash, et al.
Publicado: (2021) -
Oral Pulse Betamethasone, Methotrexate, and Combination Therapy to Treat Severe Alopecia Areata: A Randomized, Double-blind, Placebo-controlled, Clinical Trial
por: Asilian, Ali, et al.
Publicado: (2021) -
A rare form of discoid lupus erythematosus as a rosacea and angiofibroma: A case report
por: Mokhtari, Fatemeh, et al.
Publicado: (2019) -
Cutaneous horn: A rare subtype of juvenile xanthogranuloma
por: Iraji, Fariba, et al.
Publicado: (2019) -
Multiple disseminated pyogenic granuloma post–oil burning—Review literature
por: Iraji, Fariba, et al.
Publicado: (2020)